Mixed-Meal Tolerance Test (MMTT) C-Peptide and BETA-2 Score Predict Underlying β-Cell Secretory Capacity following Islet Transplantation for Type 1 Diabetes (T1D)

被引：0
|
作者：
Flatt, Anneliese
Matus, Austin M.
Gallop, Robert J.
Markmann, Eileen M.
Dalton-Bakes, Cornelia V.
Peleckis, Amy
Liu, Chengyang
Naji, Ali
Rickels, Michael R.
机构：
来源：
DIABETES | 2024年 / 73卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.2337/db24-1507-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1507-P
引用
收藏
页数：2
相关论文
共 11 条
  • [1] Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
    Besser, Rachel E. J.
    Ludvigsson, Johnny
    Jones, Angus G.
    McDonald, Timothy J.
    Shields, Beverley M.
    Knight, Bridget A.
    Hattersley, Andrew T.
    DIABETES CARE, 2011, 34 (03) : 607 - 609
  • [2] T-Cell Auto Reactivity and C-Peptide at Onset of Pediatric Type 1 Diabetes (T1D)
    Buryk, Melissa A.
    Dosch, H-Michael
    Libman, Ingrid
    Cheung, Roy K.
    Arena, Vincent C.
    Huang, Yihe
    Pietropaolo, Massimo
    Becker, Dorothy J.
    DIABETES, 2013, 62 : A352 - A352
  • [3] Postprandial C-Peptide (pCP) in Provider-Diagnosed Pediatric Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D)
    Redondo, Maria J.
    Harrall, Kylie K.
    Bird, Sarah M.
    Tosur, Mustafa
    Uysal, Serife
    Siller, Alejandro F.
    Velasquez, Horacio J.
    Muir, Andrew
    Vehik, Kendra
    Brusko, Todd M.
    Atkinson, Mark A.
    Dabelea, Dana
    Hagopian, William
    Oram, Richard A.
    DIABETES, 2024, 73
  • [4] ESTIMATING THE RISK OF DEVELOPING TYPE 1 DIABETES (T1D) THROUGH URINARY C-PEPTIDE AND ONE-WEEK HOME CGM TEST
    Montaser, E.
    Breton, M.
    Brown, S.
    Deboer, M.
    Farhy, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A175 - A176
  • [5] Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide in Patients with Type 1 Diabetes (T1D) and Hypoglycemia Unawareness
    Keymeulen, Bart
    Jacobs-Tulleneers-Thevissen, Daniel, Sr.
    Kroon, Evert J.
    Jaiman, Manasi S.
    Daniels, Mark
    Wang, Richard
    Pipeleers, Daniel
    D'Amour, Kevin
    Foyt, Howard L.
    DIABETES, 2021, 70
  • [6] Urinary C-Peptide Creatinine Ratio Is a Novel Non Invasive Alternative to the Inpatient Mixed Meal Tolerance Test in Young Onset Type 1 Diabetes
    Besser, Rachel E. J.
    Jones, Angus G.
    McDonald, Timothy J.
    Shields, Beverley M.
    Githens-Mazer, Gayle
    Wensley, Kirsty
    Knight, Bridget A.
    Hattersley, Andrew T.
    DIABETES, 2010, 59 : A18 - A18
  • [7] REASSESSMENT OF A REAL-WORLD POPULATION OF ADULTS WITH TYPE 2 DIABETES (T2D): WHEN LOW LEVELS OF C-PEPTIDE OR PRESENCE OF DIABETES AUTOANTIBODIES MIGHT INDICATE POSSIBLE TYPE 1 DIABETES (T1D)
    Aguilar, D.
    Yuan, G.
    Wade, R. L.
    Lu, J.
    Raupp, M.
    Lichtenstein, M.
    VALUE IN HEALTH, 2020, 23 : S348 - S348
  • [8] Time-to-Peak C-Peptide and Peak Glucose during an Oral Glucose Tolerance Test (OGTT) Are Independent Risk Factors for Type 1 Diabetes (T1D) in Antibody-Positive (Ab plus ) Individuals
    Ismail, Heba M.
    Xu, Ping
    Evans-Molina, Carmella
    Palmer, Jerry P.
    Sosenko, Jay
    DIABETES, 2018, 67
  • [9] A 2-Dimensional (2D) Analysis of Glucose and C-Peptide Shows a Teplizumab Effect in Individuals at Risk for Type 1 Diabetes (T1D) 3 Months after Treatment
    Sims, Emily K.
    Warnock, Megan V.
    Herold, Kevan C.
    Sosenko, Jay
    DIABETES, 2020, 69
  • [10] The 2-hr glucose and the AUC glucose-AUC C-peptide ratio as predictors of T1D in diabetes prevention trial-type 1 (DPT-1) participants
    Sosenko, JM
    Palmer, JP
    Greenbaum, CJ
    Cowie, CC
    Mahon, J
    Chase, HP
    White, NH
    Cuthbertson, DD
    Krischer, JP
    Skyler, JS
    DIABETES, 2005, 54 : A456 - A456
12